Keybank National Association OH Cuts Stock Holdings in Danaher Co. (NYSE:DHR)

Keybank National Association OH lessened its stake in Danaher Co. (NYSE:DHR) by 2.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 411,784 shares of the conglomerate’s stock after selling 11,619 shares during the period. Keybank National Association OH owned about 0.06% of Danaher worth $94,525,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in DHR. Alley Investment Management Company LLC grew its position in Danaher by 0.8% during the 4th quarter. Alley Investment Management Company LLC now owns 44,327 shares of the conglomerate’s stock valued at $10,175,000 after purchasing an additional 364 shares during the last quarter. Commerzbank Aktiengesellschaft FI raised its stake in Danaher by 18.2% during the fourth quarter. Commerzbank Aktiengesellschaft FI now owns 7,840 shares of the conglomerate’s stock valued at $1,800,000 after purchasing an additional 1,208 shares in the last quarter. Bahl & Gaynor Inc. lifted its holdings in shares of Danaher by 13.2% in the 4th quarter. Bahl & Gaynor Inc. now owns 3,061 shares of the conglomerate’s stock worth $703,000 after acquiring an additional 357 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in Danaher by 3.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,066,755 shares of the conglomerate’s stock valued at $933,524,000 after buying an additional 135,047 shares in the last quarter. Finally, Steward Partners Investment Advisory LLC increased its holdings in Danaher by 1.8% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 33,706 shares of the conglomerate’s stock valued at $7,737,000 after buying an additional 595 shares during the period. Institutional investors own 79.05% of the company’s stock.

Insider Activity

In other news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 11.10% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on DHR shares. The Goldman Sachs Group set a $250.00 target price on Danaher in a research report on Wednesday, January 15th. Raymond James restated a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. Robert W. Baird decreased their target price on Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Barclays cut their price target on Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Finally, Scotiabank initiated coverage on shares of Danaher in a report on Monday, December 23rd. They set a “sector perform” rating and a $265.00 target price for the company. Seven investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and an average price target of $278.00.

Danaher Price Performance

DHR stock opened at $205.60 on Tuesday. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The company has a market capitalization of $146.94 billion, a PE ratio of 38.94, a P/E/G ratio of 2.66 and a beta of 0.82. Danaher Co. has a 52-week low of $196.80 and a 52-week high of $281.70. The stock’s 50 day moving average is $224.11 and its two-hundred day moving average is $244.31.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the previous year, the company earned $2.09 EPS. Analysts predict that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a $0.32 dividend. The ex-dividend date is Friday, March 28th. This is a boost from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 dividend on an annualized basis and a yield of 0.62%. Danaher’s dividend payout ratio is currently 24.24%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.